ArticleACS catalysis2025
Expedited Synthesis of Axially Chiral 3-Monosilyl and 3,3'-Bis-silyl Biphenols, Binaphthols, and Phosphoramidites Enabled by Catalytic Two-Fold C-H Silylation with a Traceless Acetal Directing Group.
Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The design and development of supporting ligands have significantly propelled the discovery of new catalytic reactions and the improvement of existing ones. Among these, axially chiral biphenols and 1,1'-binaphthalene-2,2'-diol (BINOL) are some of the most privileged ligands used in a wide array of enantioselective reactions. Despite the well-established benefits of structural modifications to biphenol and BINOL scaffolds, particularly at their 3,3'-positions-for enhancing reactivity and stereofidelity in catalytic asymmetric transformations-only a limited number of 3,3'-bis-functionalized biphenols and BINOLs are currently available. Here, we report a unified strategy to rapidly access a range of axially chiral 3-monosilyl and 3,3' bis-silyl-substituted and biphenols and BINOLs as well as their corresponding 3-monosilyl and 3,3' bis-silyl BINOL-based phosphoramidites. This approach involves traceless acetal-directed, catalytic two-fold C-H silylation of axially chiral biaryls, coupled with selective monoprotodesilylation, expanding the versatility of catalytic C-H functionalization in ligand design and development. Scope studies on the augmentation of the topological space of potentially stereoselectivity-amplifying 3,3'-bis-silyl substituents in axially chiral biphenols and BINOLs were achieved through C-H silylation of biphenols and BINOLs using various dihydrosilanes, as well as the derivatization of 3,3'-silanes, leading to functionalized silane-substituted biphenols and BINOLs. Lastly, the phosphoramidation of newly synthesized 3-monosilyl and 3,3' bis-silyl BINOL and biphenols with dichlorophosphinamine provided a series of 3-monosilyl and 3,3' bis-silyl BINOL-based phosphoramidites. The efficiency of this synthetic approach is underscored by its short synthetic steps, expedited reaction times, and minimal purification, making it versatile for the synthesis of a wide array of organosilicon-functionalized axially chiral biaryls and phosphoramidites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.